ADCs Technology Services

ADCs Technology Services
Product Description

ADCs are one of the most promising new classes of drugs for treating cancers that are difficult to treat with traditional chemotherapy and believed to be the “next big thing” in the field of cancer therapy. ALL Chemistry Inc. offers our customers our state of the art Antibody-drug Conjugates technologies. We understand that each customer's needs are different and that is why we are committed to providing a tailored solution for each and every one.

Our Advantages:


Improved accuracy and reproducibility of results.

Reduced cost and time for synthesis.

Increased control over reaction conditions.

Increased ability to scale up reactions.

Increased efficiency in the synthesis of complex molecules.

Read more Show less

ALL Chemistry Inc.

  • US
  • 2022
    On CPHI since
  • 25 - 49
    Employees
Company types
Contract Research Organisation (CRO)
Manufacturer/Innovator
Wholesale/Retail
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Experienced Technicians; Product Features; Prompt Delivery; Quality Service; Small Orders Accepted; Personalized service
  • Model
    Service
  • Supplied from
    United States
More specifications Fewer specifications
Sales Markets
Show more Show less

ALL Chemistry Inc.

  • US
  • 2022
    On CPHI since
  • 25 - 49
    Employees
Company types
Contract Research Organisation (CRO)
Manufacturer/Innovator
Wholesale/Retail
View company profile

More Products from ALL Chemistry Inc. (2)

  • Custom Synthesis

    Product Custom Synthesis

    ALL Chemistry Inc. is a Contract Research Organization (CRO) that enables you to outsource a broad variety of research activities from custom synthesis of small molecules to clinical trials of a new drug, which helps you to enliven the commercial research culture toward an international, innovation-based (...
  • Desloratadine

    Product Desloratadine

    Desloratadine is a histamine H1-receptor antagonist that the FDA approved as a treatment for the relief of seasonal allergic rhinitis in patients 12 years or older.

ALL Chemistry Inc. resources (1)

  • Antibody-drug Conjugates Technology

    News Antibody-drug Conjugates Technology

    At ALL Chemistry Inc., we are proud to offer our customers our state of the art Antibody-drug Conjugates technologies. We understand that each customer's needs are different and that is why we are committed to providing a tailored solution for each and every one.
    13 Apr 2023